Identification of palsma exosomal lncRNA as a biomarker for early
diagnosis of gastric cancer
Abstract
Background, There were about 1,090,000 gastric cancer cases in 2020 in
China. The incidence and mortality rates ranked the fifth and third
among all kinds of cancers in China. Early diagnosis plays an important
role in the treatment and prognosis of gastric cancer.plasma exosome
lncRNAs, has become a promissing biomarkers with high specificity and
sensitivity for early diagnosis of cancers. In this study, the exosomes
in the plasma of patients with early gastric cancer were isolated by a
commercial kit. After identified by electron microscopy observation,
particle size analysis and Western-blot verification, the lncRNAs in the
exosomes were extracted. The lncRNAs differentially expressed in the
plasma exosomes of patients with gastric cancer were analysized by
high-throughput RNA sequencing. The differentially expressed lncRNAs
were verified by RT-qPCR in 93 patients with early gastric cancer and 49
normal controls. Electron microscopy, particle size analysis and Western
blot showed that exosomes were successfully isolated from plasma.
RNA-Seq results show that 76 lncRNAs were up-regulated and 260 lncRNAs
were down regulated in plasma exosomes of early gastric cancer patients
compared with normal controls. RT-qPCR analysis indicated that a total
of 6 lncRNAs were significantly and differentially expressed in gastric
cancer patients compared to normal controls, with 2 highly expressed and
4 lowly expressed (p < 0.05). The survival curve analysis
indicated that lncmstrg.2441832.8 and lncmstrg.2312697 had higher
sensitivity and specificity for the diagnosis of gastric cancer,
respectively and AUC curve areas were 0.6211 and 0.631, p <
0.05, respectively, which were greater than the traditional clinical
detection indexes CEA (0.61) and AFP (0.57). When combined
lncmstrg.2441832.8 and lncmstrg.2312697 in gastric cancer diagnosis, AUC
curve area reached 0.73, which was greater than CA199 (0.71).
Conclusion, lncmstrg.2441832.8 and lncmstrg.2312697 may be a potential
and promissing biomarkers for early diagnosis of gastric cance